Want to know what it takes to grow in the Nordic pharma industry over the next 3-5 years? Get the insights from Forward Thinkers Review 2.0

X

Peer-reviewed research

A vision of giving back

It is fundamental for Signum that insights generated in our research and projects become part of the open, shared body of knowledge on which the pharmaceutical and healthcare sectors advance. On this page you find a selection of our recent projects.

Signum is authorized by Statistics Denmark and the Danish Health Data Authority to access data on the “Forskermaskine”. This means that our research activities, knowledge of data security and registry data have been officially approved. Consequently, we are able to gain access to microdata for the projects we solve.

Drug survival and risk factors for ADHD medication discontinuation in adults: A Danish Nationwide Registry-based cohort study

Pelle Lau Ishøy, Kim Berg Engersgaard Johannessen, Tine Houmann, Eline Levin, Per Hove Thomsen

Predictors and long-term patterns of medication adherence to glaucoma treatment in Denmark – an observational registry study of 30 100 Danish patients with glaucoma

Andreas Høiberg Bentsen, Rikke Færgemann Hansen, Anne Cathrine Falch-Jørgensen, Louise G Dal, Emma Sabelstrøm, Magnus Brandel, Miriam Kolko

Real-world impact of once-weekly subcutaneous semaglutide after 2 years of follow-up: Results from a nationwide observational study in people with type 2 diabetes

Tina Vilsbøll, Caroline Ø. Lindahl, Nick F. Nielsen, Christian K. Tikkanen

Kill your darlings: Stop using the terms retrospective and prospective

Mikkel Zöllner Ankarfeldt, Benedikte Irene Von Osmanski, Kim Blond

The analogue substitution model: Introducing competition in the absence of generic substitution in Danish hospitals

Elisabeth Christensen, Niels Christian Hirsch, Jonas Valbjørn Andersen, Lars Holger Ehlers

Mapping Outcomes and Registries Used in Current Danish Pharmacoepidemiological Research

Charlotte Thor Petersen, Kristoffer Jarlov Jensen, Mary Rosenzweig, Benedikte Irene von Osmanski, Mikkel Zöllner Ankarfeldt, Janne Petersen

Drug survival and risk factors for ADHD medication discontinuation in adults: A Danish Nationwide Registry-based cohort study

Pelle Lau Ishøy, Kim Berg Engersgaard Johannessen, Tine Houmann, Eline Levin, Per Hove Thomsen

For more information, please contact

Anne Cathrine Falch-Jørgensen. employee at Signum, chief advisor

Anne Cathrine Falch-Jørgensen

Head of Real-World Evidence Denmark, Team Lead


acfj@signumlifescience.com

+45 61 776 975

Get in touch


Leave a message and we will get back to you ASAP.
Your personal information will be processed according to our Privacy Policy.